215 related articles for article (PubMed ID: 34238310)
1. Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma.
Wang J; Li F; Xu Y; Zheng X; Zhang C; Hu C; Xu Y; Mi W; Li X; Zhang Y
J Transl Med; 2021 Jul; 19(1):296. PubMed ID: 34238310
[TBL] [Abstract][Full Text] [Related]
2. High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.
Onieva JL; Xiao Q; Berciano-Guerrero MÁ; Laborda-Illanes A; de Andrea C; Chaves P; Piñeiro P; Garrido-Aranda A; Gallego E; Sojo B; Gálvez L; Chica-Parrado R; Prieto D; Pérez-Ruiz E; Farngren A; Lozano MJ; Álvarez M; Jiménez P; Sánchez-Muñoz A; Oliver J; Cobo M; Alba E; Barragán I
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012390
[TBL] [Abstract][Full Text] [Related]
3. Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy.
Miao YR; Liu CJ; Hu H; Yang M; Guo AY
Cells; 2022 Sep; 11(18):. PubMed ID: 36139377
[TBL] [Abstract][Full Text] [Related]
4. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract][Full Text] [Related]
5. B cells and tertiary lymphoid structures promote immunotherapy response.
Helmink BA; Reddy SM; Gao J; Zhang S; Basar R; Thakur R; Yizhak K; Sade-Feldman M; Blando J; Han G; Gopalakrishnan V; Xi Y; Zhao H; Amaria RN; Tawbi HA; Cogdill AP; Liu W; LeBleu VS; Kugeratski FG; Patel S; Davies MA; Hwu P; Lee JE; Gershenwald JE; Lucci A; Arora R; Woodman S; Keung EZ; Gaudreau PO; Reuben A; Spencer CN; Burton EM; Haydu LE; Lazar AJ; Zapassodi R; Hudgens CW; Ledesma DA; Ong S; Bailey M; Warren S; Rao D; Krijgsman O; Rozeman EA; Peeper D; Blank CU; Schumacher TN; Butterfield LH; Zelazowska MA; McBride KM; Kalluri R; Allison J; Petitprez F; Fridman WH; Sautès-Fridman C; Hacohen N; Rezvani K; Sharma P; Tetzlaff MT; Wang L; Wargo JA
Nature; 2020 Jan; 577(7791):549-555. PubMed ID: 31942075
[TBL] [Abstract][Full Text] [Related]
6. An estrogen response-related signature predicts response to immunotherapy in melanoma.
Lin M; Du T; Tang X; Liao Y; Cao L; Zhang Y; Zheng W; Zhou J
Front Immunol; 2023; 14():1109300. PubMed ID: 37251404
[TBL] [Abstract][Full Text] [Related]
7. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
Pozniak J; Pedri D; Landeloos E; Van Herck Y; Antoranz A; Vanwynsberghe L; Nowosad A; Roda N; Makhzami S; Bervoets G; Maciel LF; Pulido-Vicuña CA; Pollaris L; Seurinck R; Zhao F; Flem-Karlsen K; Damsky W; Chen L; Karagianni D; Cinque S; Kint S; Vandereyken K; Rombaut B; Voet T; Vernaillen F; Annaert W; Lambrechts D; Boecxstaens V; Saeys Y; van den Oord J; Bosisio F; Karras P; Shain AH; Bosenberg M; Leucci E; Paschen A; Rambow F; Bechter O; Marine JC
Cell; 2024 Jan; 187(1):166-183.e25. PubMed ID: 38181739
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
9. Towards In Silico Prediction of the Immune-Checkpoint Blockade Response.
Chen K; Ye H; Lu XJ; Sun B; Liu Q
Trends Pharmacol Sci; 2017 Dec; 38(12):1041-1051. PubMed ID: 29089139
[TBL] [Abstract][Full Text] [Related]
10. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy.
Sun S; Xu L; Zhang X; Pang L; Long Z; Deng C; Zhu J; Zhou S; Wan L; Pang B; Xiao Y
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915876
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients.
Pirozyan MR; McGuire HM; Emran AA; Tseng HY; Tiffen JC; Lee JH; Carlino MS; Menzies AM; Long GV; Scolyer RA; Fazekas de St Groth B; Hersey P
Front Immunol; 2020; 11():372. PubMed ID: 32210968
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis.
Wang X; Chai Z; Li Y; Long F; Hao Y; Pan G; Liu M; Li B
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316408
[TBL] [Abstract][Full Text] [Related]
13. Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy.
Gong X; Karchin R
Sci Rep; 2023 Jan; 13(1):950. PubMed ID: 36653470
[TBL] [Abstract][Full Text] [Related]
14. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
Chen IX; Newcomer K; Pauken KE; Juneja VR; Naxerova K; Wu MW; Pinter M; Sen DR; Singer M; Sharpe AH; Jain RK
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23684-23694. PubMed ID: 32907939
[TBL] [Abstract][Full Text] [Related]
15. Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.
Park C; Na KJ; Choi H; Ock CY; Ha S; Kim M; Park S; Keam B; Kim TM; Paeng JC; Park IK; Kang CH; Kim DW; Cheon GJ; Kang KW; Kim YT; Heo DS
Theranostics; 2020; 10(23):10838-10848. PubMed ID: 32929383
[No Abstract] [Full Text] [Related]
16. Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms.
Abbott CW; Boyle SM; Pyke RM; McDaniel LD; Levy E; Navarro FCP; Mellacheruvu D; Zhang SV; Tan M; Santiago R; Rusan ZM; Milani P; Bartha G; Harris J; McClory R; Snyder MP; Jang S; Chen R
Clin Cancer Res; 2021 Aug; 27(15):4265-4276. PubMed ID: 34341053
[TBL] [Abstract][Full Text] [Related]
17. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade.
Buchbinder EI; Weirather JL; Manos M; Quattrochi BJ; Sholl LM; Brennick RC; Bowling P; Bailey N; Magarace L; Ott PA; Haq R; Izar B; Giobbie-Hurder A; Hodi FS
Cancer Med; 2021 Apr; 10(8):2627-2635. PubMed ID: 33724703
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response.
Hu FF; Liu CJ; Liu LL; Zhang Q; Guo AY
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32814346
[TBL] [Abstract][Full Text] [Related]
19. A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade.
Panda A; Betigeri A; Ganesan S
Front Genet; 2022; 13():706468. PubMed ID: 35309122
[TBL] [Abstract][Full Text] [Related]
20. Functional Gene Expression Signatures from On-Treatment Tumor Specimens Predict Anti-PD1 Blockade Response in Metastatic Melanoma.
Chen S; Zhang L; Lin H; Liang Y; Wang Y
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
